Clinical Trial Update: C11-Acetate PET/CT in Multiple Myeloma: Added Value to F18-Fluorodeoxyglucose PET/CT [NA]

View source ↗

Summary

This completed trial assesses the value of C11-acetate PET/CT in multiple myeloma and its added value over F18-FDG PET/CT.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• 11C-Acetate (carbon-11 acetate)

Snippet

Sponsor: Chang Gung Memorial Hospital | Conditions: Multiple Myeloma | NA | Status: COMPLETED